Colin P. Dinney

33.7k total citations · 1 hit paper
492 papers, 21.8k citations indexed

About

Colin P. Dinney is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Colin P. Dinney has authored 492 papers receiving a total of 21.8k indexed citations (citations by other indexed papers that have themselves been cited), including 363 papers in Surgery, 145 papers in Molecular Biology and 111 papers in Oncology. Recurrent topics in Colin P. Dinney's work include Bladder and Urothelial Cancer Treatments (352 papers), Urinary and Genital Oncology Studies (208 papers) and Urological Disorders and Treatments (83 papers). Colin P. Dinney is often cited by papers focused on Bladder and Urothelial Cancer Treatments (352 papers), Urinary and Genital Oncology Studies (208 papers) and Urological Disorders and Treatments (83 papers). Colin P. Dinney collaborates with scholars based in United States, Canada and Spain. Colin P. Dinney's co-authors include Ashish M. Kamat, David J. McConkey, Arlene O. Siefker‐Radtke, H. Barton Grossman, Bogdan Czerniak, David A. Swanson, Joel W. Slaton, Xifeng Wu, H. Barton Grossman and Louis L. Pisters and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Colin P. Dinney

479 papers receiving 21.3k citations

Hit Papers

Identification of Distinc... 2014 2026 2018 2022 2014 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
    2014 1.2k citations Woonyoung Choi, Sima P. Porten et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Colin P. Dinney United States 79 12.9k 7.7k 5.8k 4.6k 3.3k 492 21.8k
Seth P. Lerner United States 66 12.6k 1.0× 4.0k 0.5× 3.6k 0.6× 3.0k 0.7× 1.7k 0.5× 375 16.4k
Yves Fradet Canada 65 8.7k 0.7× 3.4k 0.4× 4.8k 0.8× 5.2k 1.1× 1.9k 0.6× 376 16.1k
Ashish M. Kamat United States 69 13.3k 1.0× 4.1k 0.5× 4.6k 0.8× 3.2k 0.7× 1.5k 0.4× 540 18.8k
Derek Raghavan United States 50 8.9k 0.7× 3.2k 0.4× 6.6k 1.1× 7.1k 1.5× 3.1k 0.9× 296 19.1k
George N. Thalmann Switzerland 67 8.2k 0.6× 3.3k 0.4× 3.7k 0.6× 5.6k 1.2× 1.6k 0.5× 323 15.9k
William R. Fair United States 75 7.3k 0.6× 4.1k 0.5× 3.1k 0.5× 7.2k 1.6× 1.6k 0.5× 315 17.9k
Éva Compérat France 59 15.0k 1.2× 4.2k 0.5× 3.9k 0.7× 6.0k 1.3× 2.1k 0.6× 367 20.8k
John C. Cheville United States 82 7.9k 0.6× 12.5k 1.6× 7.5k 1.3× 16.6k 3.6× 5.1k 1.5× 511 27.6k
Harry W. Herr United States 86 23.0k 1.8× 3.5k 0.5× 4.8k 0.8× 5.6k 1.2× 944 0.3× 483 27.7k
Bernard H. Bochner United States 58 14.4k 1.1× 2.5k 0.3× 3.4k 0.6× 3.1k 0.7× 1.2k 0.4× 338 17.6k

Countries citing papers authored by Colin P. Dinney

Since Specialization
Citations

This map shows the geographic impact of Colin P. Dinney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin P. Dinney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin P. Dinney more than expected).

Fields of papers citing papers by Colin P. Dinney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin P. Dinney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin P. Dinney. The network helps show where Colin P. Dinney may publish in the future.

Co-authorship network of co-authors of Colin P. Dinney

This figure shows the co-authorship network connecting the top 25 collaborators of Colin P. Dinney. A scholar is included among the top collaborators of Colin P. Dinney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin P. Dinney. Colin P. Dinney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mokkapati, Sharada, Ganiraju C. Manyam, Alberto Martini, et al.. (2025). Molecular profiling of bladder cancer xenografts defines relevant molecular subtypes and provides a resource for biomarker discovery.. Translational Oncology. 52. 102269–102269. 1 indexed citations
3.
4.
Wilson, Nathaniel R., Lianchun Xiao, Jianjun Gao, et al.. (2024). Prognostic factors of relapse in surgically resected small cell neuroendocrine carcinomas of the urothelial tract (SCNEC-URO).. Journal of Clinical Oncology. 42(16_suppl). 4605–4605. 1 indexed citations
5.
Lobo, Niyati, Kelly K. Bree, Patrick J. Hensley, et al.. (2021). Reduced‐dose bacillus Calmette‐Guérin (BCG) in an era of BCG shortage: real‐world experience from a tertiary cancer centre. British Journal of Urology. 130(3). 323–330. 14 indexed citations
6.
Kukreja, Janet Baack, Roger Li, Vikram M. Narayan, et al.. (2021). Oncologic Equipoise Between Robotic and Open Radical Cystectomy. Journal of Endourology. 35(8). 1168–1176. 1 indexed citations
7.
Mokkapati, Sharada, Sima P. Porten, Vikram M. Narayan, et al.. (2020). TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder Cancer. Molecular Cancer Research. 18(6). 811–821. 6 indexed citations
8.
Choi, Woonyoung, Sharada Mokkapati, Debasish Sundi, et al.. (2019). Inhibition of urothelial carcinoma through targeted type I interferon-mediated immune activation. OncoImmunology. 8(5). e1577125–e1577125. 10 indexed citations
9.
Petros, Firas G., Roger Li, Bryan Fellman, et al.. (2019). Outcomes of nonmetastatic micropapillary variant upper tract urothelial carcinoma. Urologic Oncology Seminars and Original Investigations. 37(6). 354.e19–354.e26. 4 indexed citations
10.
Mengual, Lourdes, Mercedes Ingelmo‐Torres, J. J. Lozano Bahilo, et al.. (2018). Urine cell based DNA methylation classifier for monitoring bladder cancer. European Urology Supplements. 17(2). e1415–e1415. 3 indexed citations
11.
Roife, David, Ya’an Kang, Li Wang, et al.. (2017). Generation of patient-derived xenografts from fine needle aspirates or core needle biopsy. Surgery. 161(5). 1246–1254. 18 indexed citations
12.
Williams, Stephen B., Yuanqing Ye, Maosheng Huang, et al.. (2015). Mitochondrial DNA Content as Risk Factor for Bladder Cancer and Its Association with Mitochondrial DNA Polymorphisms. Cancer Prevention Research. 8(7). 607–613. 17 indexed citations
13.
Choi, Woonyoung, Sima P. Porten, Seungchan Kim, et al.. (2014). Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy. Cancer Cell. 25(2). 152–165. 1185 indexed citations breakdown →
14.
Ke, Hung‐Lung, Meng Chen, Yuanqing Ye, et al.. (2013). Genetic variations in micro-RNA biogenesis genes and clinical outcomes in non-muscle-invasive bladder cancer. Carcinogenesis. 34(5). 1006–1011. 23 indexed citations
15.
Adam, Liana, Matthew Wszolek, Chang Gong Liu, et al.. (2012). Plasma microRNA profiles for bladder cancer detection. Urologic Oncology Seminars and Original Investigations. 31(8). 1701–1708. 77 indexed citations
16.
Gu, Jian, Meng Chen, Sanjay Shete, et al.. (2011). A Genome-Wide Association Study Identifies a Locus on Chromosome 14q21 as a Predictor of Leukocyte Telomere Length and as a Marker of Susceptibility for Bladder Cancer. Cancer Prevention Research. 4(4). 514–521. 53 indexed citations
17.
McConkey, David J. & Colin P. Dinney. (2009). The Molecular, the Bad, and the Ugly: Preventing Bladder Cancer via mTOR Inhibition. Cancer Prevention Research. 2(12). 1001–1002. 2 indexed citations
18.
Adam, Liana, Meng Zhong, Woonyoung Choi, et al.. (2009). miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy. Clinical Cancer Research. 15(16). 5060–5072. 351 indexed citations
19.
Sabichi, Anita L., Seth P. Lerner, E. Neely Atkinson, et al.. (2006). Phase III bladder cancer chemoprevention trial with fenretinide.. Cancer Epidemiology and Prevention Biomarkers. 15. 1 indexed citations
20.
Kassouf, Wassim, Colin P. Dinney, Gordon Brown, et al.. (2005). Uncoupling between Epidermal Growth Factor Receptor and Downstream Signals Defines Resistance to the Antiproliferative Effect of Gefitinib in Bladder Cancer Cells. Cancer Research. 65(22). 10524–10535. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seth P. Lerner Breakdown of academic impact, for papers by Yves Fradet Breakdown of academic impact, for papers by Ashish M. Kamat Breakdown of academic impact, for papers by Derek Raghavan Breakdown of academic impact, for papers by George N. Thalmann Breakdown of academic impact, for papers by William R. Fair Breakdown of academic impact, for papers by Éva Compérat Breakdown of academic impact, for papers by John C. Cheville Breakdown of academic impact, for papers by Harry W. Herr Breakdown of academic impact, for papers by Bernard H. Bochner
Rankless by CCL
2026